UK markets close in 1 hour 13 minutes

NVO Jan 2024 80.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
22.270.00 (0.00%)
As of 12:57PM EST. Market open.
Full screen
Previous close22.27
Expiry date2024-01-19
Day's range22.20 - 22.30
Contract rangeN/A
Open interest832
  • GlobeNewswire

    Novo Nordisk A/S - share repurchase programme

    Bagsværd, Denmark, 04 December 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under the programm

  • Zacks

    Pfizer (PFE) Stock Down 5% as Obesity Drug Fails in Phase II

    The failure of the phase IIb study on danuglipron is a significant blow to Pfizer's (PFE) efforts to take a share of the growing market of GLP-1 drugs for treating obesity.

  • Motley Fool

    3 No-Brainer Growth Stocks to Buy in December

    Three Motley Fool contributors believe they've identified such exceptions. Here's why they think Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer growth stocks to buy in December. David Jagielski (Eli Lilly): Eli Lilly is becoming a beast in the healthcare industry.